Singapore no longer a price taker in the drug market

  • 📰 straits_times
  • ⏱ Reading Time:
  • 27 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 69%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

How Singapore is no longer a price taker in the drug market

The Agency for Care Effectiveness has helped Singapore reduce overpayment and save over $400 million. The Straits Times looks at what the agency does.Till recently, Singapore was a dream market for pharmaceutical companies.Singapore did not have a mechanism to assess the relative value and real benefits of new drugs, in order to negotiate for a fair price before subsidising a drug.

He said that if nothing was done, insurance premiums could soar to a point where many people who need coverage would no longer be able to afford it.Agency for Care Effectiveness staff was offered triple her salary - but turned it down She and her colleagues at the Agency for Care Effectiveness are highly sought after by the industry for their technical knowledge and any insider information they may have - which the companies hope might help them get their drugs approved faster, or accepted at a higher price.

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 5. in KR
 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.

대한민국 최근 뉴스, 대한민국 헤드 라인